We disclose the following European Patent application, under examination, EP15817414.4 entitled “Prenylcysteine Oxidase 1 inhibitors for the prevention and/or treatment of oxidative stress-related degenerative diseases and Prenylcysteine Oxidase 1 as diagnostic marker”, applicant Centro Cardiologico Monzino IRCCS, inventors C.B., M.B., R.B. and S.S.B., with no financial competing interest. This evidence concerns the gene PCYOX1 and neurodegenerative disease.